The role of CD45 phosphatase activity and its regulation via natural ligands to control BCR signaling strength in normal B cell development
To decipher how the BCR signal strength controls fate decision of autoreactive clones in central and peripheral tolerance mechanisms in autoimmunity/autoimmune diseases
To delineate how the B cells proliferation capacity and longevity is -along with other factors- regulated by the BCR signaling strength in immunodeficiencies and hematological malignancies
To investigate CD45 phosphatase activity regulation of BCR signaling strength in the development of effective humoral immune response against viruses
Bazsó A, Szodoray P, Shoenfeld Y, Kiss E(2024) Correction: Biomarkers reflecting the pathogenesis, clinical manifestations, and guide therapeutic approach in systemic sclerosis: a narrative review Clin Rheumatol, 43(11), 3595 DOI 10.1007/s10067-024-07147-4, PubMed 39317835
Bazsó A, Szodoray P, Shoenfeld Y, Kiss E(2024) Biomarkers reflecting the pathogenesis, clinical manifestations, and guide therapeutic approach in systemic sclerosis: a narrative review Clin Rheumatol, 43(10), 3055-3072 DOI 10.1007/s10067-024-07123-y, PubMed 39210206
Get in touch
Peter Szodoray Institute of Immunology, Rikshospitalet, Oslo University Hospital Sognsvannsveien 20., Section A2. 2nd. floor, Room: A3.2079, 0372 Oslo, Norway Phone: + 47 23 07 30 65 Cell: + 47 94 269082 Fax: + 47 23 07 35 10 Email: szodoray@gmail.com, peter.szodoray@medisin.uio.no, petszo@ous-hf.no
